Vascular Risk Factors and Alzheimer’s Disease Pathogenesis: Are Conventional Pharmacological Approaches Protective For Cognitive Decline Progression?

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 2, 2015-03 ,pp. : 257-269

Bentham Science Publishers

Access to resources Recommend Favorite

Cholinergic Nicotinic Systems in Alzheimer's Disease: Prospects for Pharmacological Intervention

By Vesey R.  

CNS Drugs, Vol. 16, Iss. 7, 2002-01 ,pp. : 485-500

Adis International

Access to resources Recommend Favorite

Pharmacological Management of Alzheimer's Disease

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 33, Iss. 1, 2003-03 ,pp. : 24-29

John Wiley & Sons Inc

Access to resources Recommend Favorite

Possible Role of Vascular Risk Factors in Alzheimer's Disease and Vascular Dementia

By  

Current Pharmaceutical Design, Vol. 20, Iss. 38, 2014-11 ,pp. : 6007-6013

Bentham Science Publishers

Access to resources Recommend Favorite

Drugs with anticholinergic properties: a potential risk factor for psychosis onset in Alzheimer's disease?

By Cancelli Iacopo   Beltrame Massimiliano   D'Anna Lucio   Gigli Gian Luigi   Valente Mariarosaria  

Expert Opinion on Drug Safety, Vol. 8, Iss. 5, 2009-09 ,pp. : 549-557

Informa Healthcare

Access to resources Recommend Favorite